Oxford Cannabinoid Technologies Holdings (OCTP) Share Price

Health Care Sector


NOTE: This is based on 1 open tips for Oxford Cannabinoid Technologies Holdings (OCTP)


Oxford Cannabinoid Technologies Holdings (OCTP)
Latest Quote Price

0.12p

Oxford Cannabinoid Technologies Holdings (OCTP)
Price Change (%)

37.50%


Latest Bid : 0.15p Latest Ask : 0.18p
High Today : 0.17p Low Today : 0.12p
This Years High : 1.30p This Years Low : 0.12p
Volume : 7,802,624 MKT Cap : £1.31M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Oxford Cannabinoid Technologies Holdings (OCTP) Overview

Oxford Cannabinoid Technologies Holdings plc was incorporated as a public limited company on
4 February 2021 with registration number 13179529. OCT is a UK-based pharmaceutical company specialised in cannabinoid drug development. The Company's
vision is to become a global leader in developing licensed prescription medicines that target the
endocannabinoid system and address significant unmet medical needs. The Group's primary market focus
is the total addressable pain market, which is estimated to be worth at least £42.5 billion(1) by
commercialisation of the first drug produced by OCT, currently anticipated to be in 2027, and as such it
initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (OCTP) Latest Tips

Type Tipster SectorScore Start date Performance
Avoid Tom Winnifrith Premium Only 2024-01-30 10:55:00 30/01/2024 79.82%

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Oxford Cannabinoid Technologies Holdings (OCTP) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 0.15p Latest Ask : 0.18p
High Today : 0.17p Low Today : 0.12p
This Years High : 1.30p This Years Low : 0.12p
Volume : 7,802,624 MKT Cap : £1.31M

Oxford Cannabinoid Technologies Holdings Overview

Oxford Cannabinoid Technologies Holdings plc was incorporated as a public limited company on
4 February 2021 with registration number 13179529. OCT is a UK-based pharmaceutical company specialised in cannabinoid drug development. The Company's
vision is to become a global leader in developing licensed prescription medicines that target the
endocannabinoid system and address significant unmet medical needs. The Group's primary market focus
is the total addressable pain market, which is estimated to be worth at least £42.5 billion(1) by
commercialisation of the first drug produced by OCT, currently anticipated to be in 2027, and as such it
initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Oxford Cannabinoid Technologies Holdings Tips

Type Tipster SectorScore Start date Performance
Avoid Tom Winnifrith Premium Only 2024-01-30 10:55:00 30/01/2024 79.82%